Clinical Trials Logo
  1. Home
  2. Iliac Artery Stenosis
  3. NCT04023370

Evaluation of the Efficacy and Safety of the Application of BeGraft Peripheral Stent Graft System

Iliac Artery Stenosis Clinical Trial

Official title:
Evaluation of the Efficacy and Safety of the Application of BeGraft Peripheral Stent Graft System in Interventional Treatment of Revascularisation for Primary Iliac Artery Stenosis and/or Occlusive Lesions: a Prospective, Multi-centre, Randomised Controlled Clinical Study

Clinical Trial Summary

The trial will be conducted to evaluate the safety and efficacy of the BeGraft Peripheral Stent Graft System in interventional revascularisation for subjects with primary iliac artery stenosis and/or occlusive lesions by conducting a multi-centre, randomised controlled clinical study with a bare metal stent system as the control, thus providing a basis for the formal use of the product in China

Clinical Trial Description

This study adopts a prospective, multi-centre, randomised controlled trial design, aiming at evaluating the efficacy and safety of the BeGraft Peripheral Stent Graft System for primary iliac artery stenosis and/or occlusive lesions. A total of 182 subjects are planned to be enrolled, with all consecutively enrolled subjects being randomly assigned to an experimental group (BeGraft group, n=91) and a control group (bare metal stent group, n=91) in the ratio of 1:1 and respectively treated using the BeGraft Peripheral Stent Graft System and the bare metal stent system. Follow-up visits are carried out for the above-mentioned 182 subjects at baseline, upon discharge from hospital, at 30 days, 6 months, 12 months and then once a year from the 2nd to 5th year following surgery. A Doppler ultrasound (DUS) examination is carried out when subjects return to hospital at 6 months following surgery, and a CT angiography (CTA) examination when returning 12 months following surgery, with telephone follow-ups being conducted at 30 days and then once a year from the 2nd to 5th year following surgery. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04023370
Study type Interventional
Source Bentley InnoMed GmbH
Contact
Status Active, not recruiting
Phase N/A
Start date September 19, 2019
Completion date August 31, 2025
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04175197 - LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries
Completed NCT00896337 - EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries Phase 3
Active, not recruiting NCT04299906 - SOLARIS Peripheral PMCF Trial N/A
Recruiting NCT03687983 - Safety and Efficacy Study of GoldenFlow Peripheral Stent System N/A
Not yet recruiting NCT05229250 - NIRS and Exercise Intensity in Patients With FLIA
Not yet recruiting NCT05377775 - Mesh Stents Study in ILIAC Complex Lesions (IMS-Study) N/A
Not yet recruiting NCT04545281 - Physician-Initiated PMCF Trial Investigating the Solaris Vascular Stent Graft for the Treatment of Iliac Lesions Phase 4
Completed NCT06012123 - BS-CERAB TECHNIQUE
Recruiting NCT04714268 - Comparison of Aorto-iliac Endovascular Interventions With and Without the EndoNaut Workstation
Recruiting NCT02793492 - Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery N/A
Enrolling by invitation NCT05117515 - Retrospective Study of the Uni-Graft® K DV Patch in the Clinical Routine
Completed NCT04343196 - Digital Variance Angiography in Diagnostic Angiographies for Effective Radiation Dose Reduction N/A
Completed NCT03844724 - Drug-eluting PTA Balloon Dilatation Catheter in the Treatment of Peripheral Artery Stenosis or Occlusion N/A